Clinical Variables and Dyspnea and Fear of Movement in Chronic Obstructive Pulmonary Patients
NCT ID: NCT06442059
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2023-10-01
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Impact of Inspiratory Muscle Training on Movement Fear Due to Dyspnea in Chronic Obstructive Pulmonary Disease
NCT03517839
The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD
NCT06041126
Determination of Body Awareness and the Functional Movement in Patients With COPD
NCT06298994
Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease
NCT05771506
Determination of Factors Related With Daily Living Activities in Severe COPD
NCT04765969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sociodemographic information (Age, Gender, Body Mass Index, Smoking history) of the individuals included in the research will be recorded.
Regarding COPD symptoms:
Whether the cough is productive or non-productive, its frequency and period Presence of sputum, type, amount, color, presence of hemoptysis, Presence of chest pain, Presence of peripheral edema, You will be asked about the presence of resting and/or exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea (PND).
1. Respiratory Muscle Strength: It will be measured using an electronic, mobile, intraoral pressure measuring device.
2. Peripheral Muscle Strength Evaluation: Quadriceps muscle strength will be evaluated using a dynomometer.
3. Physical Performance: A 6-minute walk test will be used to determine the physical fitness levels of individuals.
4. Balance Level: Mini-BEST Test will be used to determine the balance level
5. Kinesiophobia Level Due to Dyspnea:
It will be evaluated with the Breathlessness Beliefs Questionnaire (BBQ). When the literature was examined, no study was found that examined all of these factors together in patients with COPD. Existing studies have shown that the effects of variables are different and it is stated that more studies are needed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
copd
Patients over the age of 45 who have been diagnosed with COPD and whose clinical condition is stable
Kinesiophobia Level Due to Dyspnea
Kinesiophobia Level Due to Dyspnea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesiophobia Level Due to Dyspnea
Kinesiophobia Level Due to Dyspnea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kırıkkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saniye Aydoğan Arslan
assoc. prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saniye Aydoğan Arslan
Kırıkkale, Kırıkkale, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kırıkkaleu-Caglanyetim
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.